BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2002
View Archived Issues
Cell Therapeutics presents data on metabolism of CT-2103
Read More
LErafAON improves tumor chemotherapy effectiveness in preclinical studies
Read More
Second-generation cell cycle inhibitors with improved solubility, oral bioavailability
Read More
Taxane-based MDR reversal agents presented at AACR meeting
Read More
Data presented at AACR meeting demonstrate promise of novel family of antimitotic agents
Read More
Targeted drug delivery using A-Z-CINN Linker proved effective in breast cancer model
Read More
Dopamine stabilizer to be evaluated in schizophrenic patients
Read More
PSP-94 may have an expanded role in prostate cancer, inhibiting metastasis and hypercalcemia
Read More
Sulfonamide 5-HT6 antagonist with advantageous pharmacological profile
Read More
Synthesis and use of integrin receptor antagonists described by Pharmacia team
Read More
Pfizer presents new 5-HT reuptake inhibitors and uses thereof
Read More
New series of protein kinase inhibitors useful for cancer, neurodegenerative disorders, etc.
Read More
Abbott reveals newly synthesized PTP1B inhibitors
Read More
Potent and selective MC4 receptor agonists designed at Roche
Read More
Boehringer Ingelheim research focuses on PTK inhibitors
Read More
Monoclonal antibody-auristatin E conjugates effective in established tumors
Read More
SGN-30, a chimeric anti-CD30 MAb, in the treatment of Hodgkin's disease
Read More
MedImmune licenses cancer technologies
Read More
Abbott makes tender offer to acquire Hokuriku Seiyaku
Read More
Paxil CR launched in U.S.
Read More
Cohesion licenses PEG technology to Zycos
Read More
Telik extends TRAP collaboration with Sanwa Kagaku
Read More
MAA filed for Olux in U.K.
Read More
Patient treatment initiated in phase II trial of Aryplase in MPS VI
Read More
